Company intelligence / Profile preview

Molsid

Lyon, Auvergne-Rhône-Alpes, Francemolsid.com ↗

Ownership: Private
Employees: ~33
Development stage: Commercial

Overview

Molsid has developed a proprietary platform for robust fluorogenic precipitation-based probes enabling rapid and sensitive detection of enzyme activity. Their lead product is a rapid test kit for detecting antimicrobial resistance directly from primary clinical samples, delivering results in under two hours. The company’s technology is positioned to address urgent needs in early diagnostics for AMR and other critical healthcare challenges.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Fluorogenic molecular probes (for enzyme detection)Diagnostic kits and in vitro diagnostic medical devices (IVDs)
Industry: Protein Biomarker Diagnostics

Drug pipeline

2 assets

Early Warning Beta-lactamases Diagnostic

Commercial

Indications: Beta-lactamase detection

1 more asset in the full pipeline.

Request access →

Partnerships

ORSET Group (investor/partner)Pulsalys SATT Lyon (investor/partner)University of Lyon – ENS de Lyon (spin-off origin/collaboration)

Beyond the preview

Go deeper on Molsid.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Molsid.

Explore the full profile